SARS-CoV-2 Vaccination and Autoimmune Neuropathies: Rebalancing the Risk

With every influenza vaccination, the question is asked: "Have you ever had Guillain-Barre syndrome?" If so, the potential vaccination recipient is advised to talk to their doctor before proceeding, and the physician will invariably recommend against it. The topic is widely discussed in patient and physician networks, with stakeholders holding firm convictions for or (more commonly) against vaccination. Naturally, with the emergence of the COVID-19 pandemic and the reality of administering billions of SARS-CoV-2 vaccinations across the globe, the anxiety within the inflammatory neuropathy community and among clinicians caring for patients with GBS and CIDP has been raised to new heights.